AstriVax Strengthens Leadership Team by Welcoming Chief Development Officer (CDO) Dr. Mathieu Peeters and Chief Financial Officer (CFO) Barbara Freitag
Dr. Mathieu Peeters brings an extensive clinical vaccine development track record from his senior roles at GSK Vaccines.
- Dr. Mathieu Peeters brings an extensive clinical vaccine development track record from his senior roles at GSK Vaccines.
- Barbara Freitag joins AstriVax as an accomplished CFO in the biotech sector.
- Leuven, Belgium, October 10, 2023 – AstriVax is pleased to announce that Dr. Mathieu Peeters and Barbara Freitag have joined the company’s leadership team as Chief Development Officer and Chief Financial Officer, respectively.
- With AstriVax soon entering into clinical stage, I am excited that Mathieu has joined us as CDO to steer our clinical vaccine development.